Prediction and Prevention of Preeclampsia by First Trimester Ultrasound

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

602 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the Fetal Medicine Foundation algorithm for individual risk calculation for preeclampsia (PE) and pregnancy induced hypertension (PIH) is suitable to identify women in high risk of developing these diseases in a Norwegian population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Left Ventricular and Endothelial Function in Preeclampsia

NCT00201500

Preeclampsia

COMPLETED

Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study

NCT07299773

Preeclampsia Preeclampsia (PE) Hypertensive Disorder of Pregnancy

NOT_YET_RECRUITING

Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy

NCT04075708

Preeclampsia

COMPLETED

Hemodynamic Measurements in Women With Serious Preeclampsia

NCT00199810

Preeclampsia

COMPLETED

Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies

NCT04783597

High Risk Pregnancy Arterial Stiffness Pre-Eclampsia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It has been shown that low dose acetylsalicylic acid (ASA) in pregnancy reduces adverse outcome of pregnancy in women that have high risk of developing preeclampsia (PE). It is a challenge for the clinician to identify the high risk women. Doppler blood flow measurements in uterine arteries in second trimester have been shown useful to predict the development of the disease but prophylactic treatment with ASA from this point in pregnancy has not been proven effective. Fetal Medical Foundation has developed an algorithm that calculates individual risks for PE/ PIH based on Doppler blood flow measurements and anamnestic information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preeclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant
* Nulliparous
* Para 1+ with previous preeclampsia or gestational hypertension
* last menstrual period (LMP) pregnancy length at inclusion \< 13 weeks
* Residence in Trondheim + 8 surrounding municipalities